Dermatitis Artefacta Questions & Answers

1. Lavery MJ, Stull C, McCaw I, Anolik RB. Dermatitis artefacta. Clin Dermatol. 2018 Nov - Dec. 36 (6):719-722. [QxMD MEDLINE Link].

2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Washington DC: American Psychiatric Association; 2022. 287.

3. Shah KN, Fried RG. Factitial dermatoses in children. Curr Opin Pediatr. 2006 Aug. 18(4):403-9. [QxMD MEDLINE Link].

4. Gupta MA, Gupta AK, Ellis CN, Koblenzer CS. Psychiatric evaluation of the dermatology patient. Dermatol Clin. 2005 Oct. 23(4):591-9. [QxMD MEDLINE Link].

5. Saez-de-Ocariz M, Orozco-Covarrubias L, Mora-Magana I, et al. Dermatitis artefacta in pediatric patients: experience at the national institute of pediatrics. Pediatr Dermatol. 2004 May-Jun. 21(3):205-11. [QxMD MEDLINE Link].

6. Ozmen M, Erdogan A, Aydemir EH, Oguz O. Dissociative identity disorder presenting as dermatitis artefacta. Int J Dermatol. 2006 Jun. 45(6):770-1. [QxMD MEDLINE Link].

7. Urpe M, Pallanti S, Lotti T. Psychosomatic factors in dermatology. Dermatol Clin. 2005 Oct. 23(4):601-8. [QxMD MEDLINE Link].

8. Sambhi R, Lepping P. Psychiatric treatments in dermatology: an update. Clin Exp Dermatol. 2010 Mar. 35(2):120-5. [QxMD MEDLINE Link].

9. Cohen AD, Vardy DA. Dermatitis artefacta in soldiers. Mil Med. 2006 Jun. 171(6):497-9. [QxMD MEDLINE Link].

10. Baranska-Rybak W, Cubala WJ, Kozicka D, Sokolowska-Wojdylo M, Nowicki R, Roszkiewicz J. Dermatitis artefacta--a long way from the first clinical symptoms to diagnosis. Psychiatr Danub. 2011 Mar. 23(1):73-5. [QxMD MEDLINE Link].

11. Ehsani AH, Toosi S, Shahshahani MM, Arbabi M, Noormohammadpour P. Psycho-cutaneous disorders: an epidemiologic study. J Eur Acad Dermatol Venereol. 2009 Mar 11. [QxMD MEDLINE Link].

12. Koblenzer CS. Dermatitis artefacta. Clinical features and approaches to treatment. Am J Clin Dermatol. 2000 Jan-Feb. 1(1):47-55. [QxMD MEDLINE Link].

13. Ilter N, Adisen E, Gurer MA, Kevlekci C, Tekin O, Sayin A. Dermatitis artefacta masquerading as pyoderma gangrenosum. Int J Dermatol. 2008 Sep. 47(9):975-7. [QxMD MEDLINE Link].

14. Harries MJ, McMullen E, Griffiths CE. Pyoderma gangrenosum masquerading as dermatitis artefacta. Arch Dermatol. 2006 Nov. 142(11):1509-10. [QxMD MEDLINE Link].

15. Brod CS, Garbe C, Schleicher J, Rocken M, Schilling M. Acquired haemophilia mimicking dermatitis artefacta. Acta Derm Venereol. 2009. 89(2):194-5. [QxMD MEDLINE Link].

16. Angus J, Affleck AG, Croft JC, Leach IH, Slater DN, Millard LG. Dermatitis artefacta in a 12-year-old girl mimicking cutaneous T-cell lymphoma. Pediatr Dermatol. 2007 May-Jun. 24(3):327-9. [QxMD MEDLINE Link].

17. Giunta A, Demin F, Campione E, Chimenti S, Bianchi L. Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda. J Eur Acad Dermatol Venereol. 2008 Dec 22. [QxMD MEDLINE Link].

18. Koblenzer CS. The current management of delusional parasitosis and dermatitis artefacta. Skin Therapy Lett. 2010 Oct. 15(9):1-3. [QxMD MEDLINE Link].

19. Mohandas P, Bewley A, Taylor R. Dermatitis artefacta and artefactual skin disease: the need for a psychodermatology multidisciplinary team to treat a difficult condition. Br J Dermatol. 2013 Sep. 169(3):600-6. [QxMD MEDLINE Link].

20. Shenefelt PD. Complementary psychocutaneous therapies in dermatology. Dermatol Clin. 2005 Oct. 23(4):723-34. [QxMD MEDLINE Link].

21. Gupta MA, Guptat AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001 Nov. 15(6):512-8. [QxMD MEDLINE Link].

22. Lee CS, Koo J. Psychopharmacologic therapies in dermatology: an update. Dermatol Clin. 2005 Oct. 23(4):735-44. [QxMD MEDLINE Link].

23. Lowry CL, Bewley A, Taylor R. Facial ulcer treated with olanzapine. Clin Exp Dermatol. 2013 Jul. 38(5):504-6. [QxMD MEDLINE Link].

24. Wong JW, Nguyen TV, Koo JY. Primary psychiatric conditions: dermatitis artefacta, trichotillomania and neurotic excoriations. Indian J Dermatol. 2013 Jan. 58 (1):44-8. [QxMD MEDLINE Link].

John YM Koo, MD Professor and Vice Chairman, Department of Dermatology, University of California, San Francisco, School of Medicine; Director, UCSF Psoriasis Treatment Center

John YM Koo, MD is a member of the following medical societies: American Academy of Dermatology, American Psychiatric Association, National Psoriasis Foundation

Disclosure: Nothing to disclose.

Patricia T Ting, MD, MSc, FRCPC, LMCC(Canada) Clinical Assistant Professor, Cumming School of Medicine, University of Calgary, Canada

Patricia T Ting, MD, MSc, FRCPC, LMCC(Canada) is a member of the following medical societies: Alberta Medical Association, American Academy of Dermatology, Canadian Dermatology Association, Canadian Medical Association, European Academy of Dermatology and Venereology, Royal College of Physicians and Surgeons of Canada

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Abbvie<br/>Received income in an amount equal to or greater than $250 from: Abbvie<br/>advisory board member.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

David F Butler, MD Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Edward F Chan, MD Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine

Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Jacek C Szepietowski, MD, PhD Professor, Vice-Head, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University; Director of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Poland

Disclosure: Stiefel GSK Company Salary Employment; Orfagen Consulting fee Consulting; Maruho Consulting fee Consulting; Astellas Consulting fee Consulting; Abbott Consulting fee Consulting; Leo Pharma Consulting fee Consulting

• Print this section
• Print the entire contents of
• Print the entire contents of article